Member Info for Brighty1

Very low market cap so this could explode. It went up over 300% earlier this year on a hint of news. As examples in the sector, Altn has gone from 0.45 to 3.15 and AAZ has gone from 5p in 2016 to 173p in 2019. The message is clear. Hold for 'gold', literally. e.g. AAZ 5p in 2016 AAZ 30p in 2017 AAZ 90p in 2018 AAZ 173p in 2019 AAZ 146p today
If you hold TYM for 2-3 years and the AAZ experience is repeated here the gains will be huge for TYM share holders.
Good luck, Brighty

The comment that grabbed my attention from the RNS today was regarding the market over looking their royalty interests, pasted below
"The recent high-grade gold discoveries at the nearby Aamurusko deposit and in the wider Risti Project area bode well for the future development of Kaaresselkä and the realisation of our royalty interests which I suspect have been overlooked by the market".
Looks as though at last - things might be getting interesting. This went to 0.9 earlier this year and was over 2p two years ago and over 5p five years ago and over 10p seven years ago. Dyor and good luck, Brighty

I believe IQE will be in or around the 70's by results day. We can then move in to the 90's with the % gain I'm expecting following our results. This was over 145p in 2018 and was over 170p in 2017. Our customers are reporting excellent results so the impact should be very favourable for us. I feel that IQE will have an all time high share price within the next 12 months. i.e. Over 170p. Our incoming RNS is going to be a good one for IQE in my opinion. Good luck, Brighty

If this was any other pharma plc they would have informed the stock market of said developments to enhance the share price. This diffidence is holding back the share price to the point where if they don't change their modus operandi the true value of our company will not be achieved. I'm not happy about Sareum being sub 1 penny based on what we know and what is being regularly unearthed on this forum. It is the board's duty to manage the share price and not hold it back. This is becoming unacceptable. Brighty

Another key factor for N4P investors is that back in May the company raised over £2million GBP. At the time the CEO said
“The funds raised will allow us to accelerate work to aid our commercial discussions to license Nuvec". Since then they have issued a further release stating that the ceo is concentrating on collaborations. I think there is a lot going on behind the scenes here re licencing and or M&A activity. Evotec could be a likely suitor. They have been working together with N4P and they will know before anyone else how P3 is going. It would make sense for them to buy N4P before a bidding war. Dyor and good luck, Brighty

ODX is looking really good for September. We should hear more news on:
* The completion of the tech transfer
* Self Testing update
* UK Govt supply deal for RTC
* UK widespread testing blueprint
* Start of production of 100k + units per day
Good luck, Brighty

I'm forecasting a new 12 month high following the results in September.I hope IQE will be in the 70's by results day so we can head in to the 90's with the 20% to 25% gain I'm expecting. Remember that this was over 145p in 2018 and was over 170p in 2017. Based on what our customers are reporting I'd say that IQE will have an all time high share price within the next 12 months. i.e. Over 170p. September's RNS is going to be a good one for IQE in my opinion. Good luck, Brighty

The tweet today was rather like a speeding ticket. It has defused the momentum. The plan looks to be to keep this sub 1p. Why? I can't fathom it out. I've been invested in SAR for a decade (to make money) so this is just another frustrating episode of an opportunity blown. Have a great weekend everyone. Good luck, Brighty

This should not still be a sub 1p share. A non-committal RNS to wet the appetite of the market is what is required to launch Sareum to 2-3p today so that when the actual milestone (or other) news hits it take us up to 10P+ and above to 20p, 30p 40p etc. The question is why the radio silence? It's time for SAR to take a leaf from how ODX, SNG, NCYT, AVCT, HEMO, PYC, N4P etc handle their comms/PR and help the share price move upwards. Good luck, Brighty

As I've said numerous times before where Sareum differ from the pharmaceutical rivals that I have highlighted previously is that whilst the others would probably issue a statement to enable them to get on the runway ready for take-off our PR / comms approach leaves us in the hanger, not even at the departure gate - let alone on the runway. A non-committal RNS statement to wet the appetite of the market is what is required imminently to launch Sareum to 2-3p so that when the actual milestone (or other) news hits it take us up to 10P+ and above to 20p, 30p 40p etc. It is not rocket science, it's not ramping - it is just good management of a plc's share price. The over cautious radio silence is damaging the prospects of our share price reaching its true potential. This should not still be a sub penny stock. Where is the ambition from the bod to take the share price higher. They need to be proactive not reactive. Good luck, Brighty

If this was N4P, AVCT, ODX, PYC, NCYT, HEMO, SNG, YGEN etc there would be a 7am RNS tomorrow with some news to keep the momentum going. Come on SAR play the game this time and help the share price move from being a sub penny stock. Good luck, Brighty

Damion, you have proved to be an inspired poster. Well done on your research. I'm hoping though that your prediction of a 7.5p takeover by Amgen in August was a low ball suggestion! Good luck, Brighty

Well if this was the Ceo of Sng, Avct, ncyt, odx, Pyc, N4p etc they would of course be communicating this to create hunger in the company but not our ceo and chair. They are happy to keep us a sub 1p share. This approach to pr / comma is damaging To our investments in Sar. It has to change or the gains in share price we expect are not going to happen. Come on Tim start communicating to help put our share price on the map. Brighty

Once the AO results have been fully digested by the investment community this will add even more weight to the BWNG investment story. With comments from AO such as "This reaffirms our belief that this is a structural shift in demand where customers have found a better way to shop" (i.e. online is the future and the high street is looking grim) and "revenue growth in the UK up 58.9%" it is little wonder that the BWNG share price is quickly heading back to where it was at the start of 2020 - Over £1.50p. Good luck, Brighty

Well N4P, AVCT, ODX, PYC, NCYT, HEMO, SNG, YGEN and several other pharma businesses have been able to generate momentous shareholder gains / value for their investors in 2020. As a Chairman or CEO you can’t keep on disregarding what many of your rivals are doing with their PR/comms if their strategy is creating value for their shareholders and your approach is actually suppressing your own share price. You need to learn from your rivals approach and adapt accordingly. It is not ramping - it’s called creating “significant shareholder value”. Good luck, Brighty

I don't think Stephen Parker has added any value at all to the Sareum business and he should be removed by an EGM if things have not changed in the next few months. I would also like to see a CEO appointed who has a more commercial approach to running the business. TM is better to suited to being a scientist with JR than fronting the business and should move sideways to a scientific role. The bod are collectively failing to ignite investor hunger in Sareum as the share price illustrates. We have seen how rival pharma co's have handled the last 6 months. Sar's approach is hurting our investment in the company. Brighty

WOW! AO revenue growth in UK is up 58.9% - which is clearly very good news for BWNG. "The trading momentum announced at the time of our preliminary results in July has continued and the significant change in demand for AO's products and services has been maintained. As a result, in the four months ended 31 July 2020 we have recorded strong year-on-year revenue growth in the UK of 58.9% and of 91.5% in Germany"
In the small print this is also very interesting re changing habits of shoppers: "This reaffirms our belief that this is a structural shift in demand where customers have found a better way to shop"
Basically saying Online is the new normal. Good news for BWNG. Good luck, Brighty

Q3 will hopefully be the game changer. Super progress made in the last year. 3.5p next ahead of results which should propel this significantly higher based on progress and POG. Good luck, Brighty

Spot on Phoebus regarding the next 5 weeks for Dunrobin, plus the fact that the Timor-Leste & Peru operations are financed through 2020 / 2021 illustrates that things are starting to become really exciting for BOIL share holders. Remember also that we have a tiny mcap of £4.5million - so if the next announcement is as you suggest re Dunrobin or perhaps a partial sale or JV of one of our other assets, that we have percentage holdings in, then the BOIL share price could multiply x 5 or even x 10 times the current price. Good luck, Brighty

This is what the BWNG share does if you check its history over the last few months. It rises quickly, has a little drop back before rising again quickly. No reason why this trend is not going to continue as this was over £1.50 at the start of this year and was over £2.80 in 2018. Lots of considerable gains to come. See the N Brown plc investor page for where the management are taking this online business. Very impressive strategy. Plus follow the money....some big buys over the last few weeks and yet again nearly 1,000 shares traded already today. Good luck, Brighty